Overview
Yu Oyama practices in Kamogawa, Japan. Oyama is rated as an Experienced expert by MediFind in the treatment of Hemangiopericytoma. Their top areas of expertise are Angiosarcoma of the Liver, Mediastinal Tumor, NUT Carcinoma, and Urothelial Cancer.
Their clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hemangiopericytoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Angiosarcoma of the LiverOyama isExperienced. Learn about Angiosarcoma of the Liver.
- Bladder CancerOyama isExperienced. Learn about Bladder Cancer.
- Heart TumorOyama isExperienced. Learn about Heart Tumor.
- HemangiopericytomaOyama isExperienced. Learn about Hemangiopericytoma.
- Lung CancerOyama isExperienced. Learn about Lung Cancer.
- Mediastinal TumorOyama isExperienced. Learn about Mediastinal Tumor.